Kynurenine pathway metabolites and suicidality
Elena Y Bryleva1, Lena Brundin1
1Laboratory of Behavioral Medicine, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
Neuropharmacology
|January 29, 2016
Summary
Suicide is linked to inflammation and an imbalanced kynurenine pathway, affecting neuroactive metabolites. Targeting this pathway may offer new treatments for suicidal behavior.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- Suicide is a significant global health issue with over 800,000 annual deaths.
- Neurobiological underpinnings of suicidal ideation and behavior remain incompletely understood.
- Elevated inflammation in the central nervous system and peripheral blood is observed in suicidal patients.
Purpose of the Study:
- To explore the association between inflammation and the kynurenine pathway in suicidal patients.
- To investigate the role of kynurenine pathway dysregulation in the neurobiology of suicidality.
- To highlight potential therapeutic targets within the kynurenine pathway for suicidal behavior.
Main Methods:
- Review of existing evidence on inflammation and the kynurenine pathway in suicidality.
- Analysis of metabolite changes in suicidal patients, focusing on the kynurenine pathway.
- Examination of the link between kynurenine metabolites, glutamate neurotransmission, and neuroinflammation.
Main Results:
- Evidence suggests a dysregulation of the kynurenine pathway in suicidal patients.
- Increased levels of quinolinic acid (NMDA receptor agonist) and decreased neuroprotective metabolites are observed.
- This imbalance may contribute to suicidality through altered glutamate neurotransmission and neuroinflammation.
Conclusions:
- Dysregulation of the kynurenine pathway, leading to an imbalance of neuroactive metabolites, is associated with suicidality.
- Targeting kynurenine pathway enzymes presents a promising avenue for novel therapeutic strategies.
- Further research into the kynurenine pathway's role in suicidal behavior is warranted.
More Related Videos
Related Concept Videos
01:28Biosynthesis of Nucleic Acids
1.5K
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.5K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
60
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
60
01:29Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
109
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
865
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
865